Michael Amoroso insider trades: Precision Biosciences (DTIL) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | DTIL | ↓ Sell | 20,559 | $3.84 | $79K | Direct | Feb 19, 2026 (1d) |
| Jan 22, 2026 | DTIL | ↓ Sell | 34,799 | $4.17 | $145K | Direct | Jan 22, 2026 (0d) |
| Nov 3, 2025 | DTIL | ↓ Sell | 3,409 | $6.49 | $22K | Direct | Nov 4, 2025 (1d) |
| Mar 24, 2025 | DTIL | ↓ Sell | 964 | $5.56 | $5K | Direct | Mar 25, 2025 (1d) |
| Jan 21, 2025 | DTIL | ↓ Sell | 36,838 | $4.67 | $172K | Direct | Jan 22, 2025 (1d) |
| Nov 4, 2024 | DTIL | ↓ Sell | 3,012 | $8.19 | $25K | Direct | Nov 5, 2024 (1d) |
| May 2, 2024 | DTIL | ↓ Sell | 1,526 | $10.32 | $16K | Direct | May 3, 2024 (1d) |
| Jan 22, 2024 | DTIL | ↓ Sell | 137,390 | $0.36 | $49K | Direct | Jan 23, 2024 (1d) |
| Nov 3, 2023 | DTIL | ↓ Sell | 125,025 | $0.40 | $50K | Direct | Nov 6, 2023 (3d) |
| Sep 27, 2023 | ABEO | ↓ Sell | 5,508 | $3.91 | $22K | Direct | Sep 29, 2023 (2d) |
| Sep 20, 2023 | ABEO | ↓ Sell | 327 | $3.90 | $1K | Direct | Sep 22, 2023 (2d) |
| Jun 20, 2023 | ABEO | ↓ Sell | 338 | $4.45 | $2K | Direct | Jun 21, 2023 (1d) |
| Mar 22, 2023 | DTIL | ↓ Sell | 46,999 | $0.82 | $39K | Direct | Mar 23, 2023 (1d) |
| Mar 20, 2023 | ABEO | ↓ Sell | 268 | $2.33 | $624 | Direct | Mar 21, 2023 (1d) |
| Mar 3, 2023 | ABEO | ↓ Sell | 1,002 | $2.38 | $2K | Direct | Mar 3, 2023 (0d) |
| Oct 17, 2022 | DTIL | ↓ Sell | 11,006 | $1.32 | $15K | Direct | Oct 18, 2022 (1d) |
| Sep 30, 2021 | ABEO | ↓ Sell | 45,409 | $1.09 | $49K | Direct | Oct 4, 2021 (4d) |
| Mar 31, 2021 | ABEO | ↓ Sell | 45,409 | $1.87 | $85K | Direct | Apr 2, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DTIL insiders
Open-market trades in the last 12 months
About Michael Amoroso's insider trades
Michael Amoroso is President and CEO at Precision Biosciences (DTIL). Since Mar 31, 2021, Michael has reported no open-market purchases and 18 sales worth $778K on SEC Form 4. In the last 12 months: 2 sales ($224K).
Their filings also include grants and awards (20 filings), option exercises (11 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DTIL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.